摘要
目的:探讨瑞芬太尼静脉自控麻醉应用于产妇分娩中的镇痛效果及产生的不良反应。方法:将经笔者所在医院检查适于阴道分娩并愿意接受麻醉镇痛的60例足月健康初产妇作为实验研究对象。将采用瑞芬太尼静脉自控镇静麻醉的30例产妇作为观察组,将采用硬膜外阻滞自控镇痛麻醉的30例产妇作为对照组。比较两组产妇不同镇痛方式下的镇痛效果、各产程时间、不良反应发生率、器械助产率、剖宫产率、催产素使用率。比较两组新生儿Apgar评分。结果:两组产妇的镇痛效果、剖宫产率、催产素使用率比较差异无统计学意义(P>0.05)。观察组产妇的第一产程和第二产程明显小于对照组(P<0.05);观察组产妇在镇痛过程有困倦情况发生,镇静程度高于对照组(P<0.05);其低血氧饱和度发生率高于对照组(P<0.05),其他不良反应发生率两组相似;对照组产妇的器械助产率更高,与观察组比较差异有统计学意义(P<0.05)。两组新生儿Apgar评分相似。结论:瑞芬太尼静脉自控镇痛麻醉虽然存在不良反应但均可缓解,对孕妇和胎儿不会造成影响,可以用于产妇的分娩镇痛中。
Objective：To investigate the adverse reaction and childbirth analgesia effect of patients controlled intravenous anesthesia Remifentanil for maternity.Method：60 cases of early maternal health in hospital after checking apply to vaginal delivery and willing to accept the term narcotic analgesic were as experimental subjects.The controlled intravenous sedation using Remifentanil anesthesia in 30 women were as the observation group,epidural analgesia anesthesia 30 women served as control group.Analgesia analgesia were compared under different mothers,each labor time,incidence of adverse reactions,instrumental delivery rate,cesarean rate,oxytocin usage,Apgar score were compared.Result：The two groups of maternal analgesia,cesarean rate,oxytocin usage were similar,the differences were no significant difference（P〉0.05）.Maternal first stage and second stage of labor in the observation group were significantly less than those in the control group（P〈0.05）;observation group maternal analgesia drowsiness occurs,the degree of sedation was higher in the observation group than that in the control group（P〈0.05）;the incidence of oxygen saturation was higher in the observation group than that in the control group（P〈0.05）,other adverse reactions were similar incidence, mothers instrumental delivery rate in the control group was higher than that in the observation group（P〈0.05）.Apgar score was similar in two groups.Conclusion：PCIA Remifentanil anesthesia although has side effects,but it can relieve,pregnant women and the fetus will not be affected,can be used for labor analgesia in women.
出处
《中外医学研究》
2014年第30期3-5,共3页
CHINESE AND FOREIGN MEDICAL RESEARCH
